CLS and Image Guided Therapy prepare agreement for development and commercialisation of product for MR-guided temperature monitoring
Clinical Laserthermia Systems AB (publ) and the French company Image Guided Therapy SA (IGT) have in recent days signed a term sheet, stating the main conditions of the cooperative agreement, that the parties are aiming to sign. The purpose of the collaboration is to jointly develop and commercialise a software product, offering doctors MR-supported, optimal conditions for measuring and controlling the temperatures during treatment with focal laser ablation or CLS’ imILT procedure.
IGT is a French medtech company that, utilising research work from the university in Bordeaux, has developed products in the field of MR guided, minimally invasive cancer treatments. IGT has been involved with two main developments: MR guidance for RF ablation procedures and MR guided focused ultrasound ablation devices (MRgFUS).
- IGT has extensive knowledge in software development for medtech products and we plan for a development project in close collaboration, where both companies contribute with their respective expertise in creation of this new product. As previously stated our goal is to offer doctors, when choosing the TRANBERG®-system, an improved workflow where they, in the best way possible, can monitor the treatment procedure. I am very pleased with the term sheet which now is in place, with the objective to have a finalized agreement during the third quarter this year, said Lars-Erik Eriksson, CEO at CLS.
CLS markets and sells TRANBERG® | Thermal Therapy Systemfor image guided FLA on the US and European markets and for imILT treatment in Europe. Image guided means that the physician uses magnetic resonance images (MRI) or ultrasound images, for example, to identify targets, guide placement of instruments and for monitoring of the FLA treatment.
Read more about Image Guided Therapy
This pressrelease has been translated from Swedish. The Swedish text shall govern for all purposes and prevail in case of any discrepancy with the English version.
Lars-Erik Eriksson, CEO, Clinical Laserthermia Systems AB (publ)
Tel: +46 – (0)702 – 90 33 00 E-mail: lee@clinicallaser.se
Clinical Laserthermia Systems AB (publ), develops and sells the TRANBERG®|Thermal Therapy System and specially designed sterile disposable products for safe, gentle and effective treatment of cancerous tumors. The products are marketed for image-guided laser ablation and for treatment with immunostimulating interstitial laser thermotherapy, imILT®. The company, which is headquartered in Lund Sweden and have subsidiaries in Berlin, Germany and Boston, MA,USA, is listed Nasdaq First North under the ticker CLS B. Certified Adviser is Västra Hamnen Corporate Finance. Further information is available on the company’s website: www.clinicallaser.se